Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation

Journal of Cellular Biochemistry

Volumn 112, Issue 7, 2011, Pages 1773-1786

  Semirale, Anthony A ^a,b   Zhang, Xiao Wei ^a,b   Wiren, Kristine M ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Adipogenesis; Androgen Receptor; Body Composition; Lean Mass; Msc; Testosterone

Indexed keywords

ADIPONECTIN; ANDROGEN RECEPTOR; CCAAT ENHANCER BINDING PROTEIN ALPHA; GLUCOSE TRANSPORTER 4; INSULIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; BODY FAT; BODY FAT DISTRIBUTION; BROWN ADIPOSE TISSUE; CELL PROLIFERATION; COLONY FORMING UNIT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOOD INTAKE; GENE EXPRESSION; GENOTYPE; GLUCOSE TOLERANCE TEST; IN VIVO STUDY; LEAN BODY WEIGHT; LIPID STORAGE; LOCOMOTION; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ADIPOGENESIS; ADIPOSITY; ANIMALS; BLOOD GLUCOSE; BODY COMPOSITION; BODY WEIGHT; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELL SIZE; COLONY-FORMING UNITS ASSAY; EATING; FEMALE; GLUCOSE TOLERANCE TEST; INSULIN; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; RECEPTORS, ANDROGEN; RECOMBINANT PROTEINS; SKIN; TESTIS;

MUS MUSCULUS;

EID: 80051492645     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23098     Document Type: Article

References (51)

1. Bassil N, Alkaade S, Morley J. 2009. The benefits and risks of testosterone replacement therapy: A review. Ther Clin Risk Manag 5:427-448.
2. Bhasin S. 2003. Regulation of body composition by androgens. J Endocrinol Invest 26:814-822. (Pubitemid 38049163)
3. Bhasin S, Taylor W, Singh R, Artaza J, Sinha-Hikim I, Jasuja R, Choi H, Gonzalez-Cadavid N. 2003. The mechanisms of androgen effects on body composition: Mesenchymal pluripotent cell as the target of androgen action. J Gerontol A Biol Sci Med Sci 58:M1103-M1110.
4. Billon N, Monteiro M, Dani C. 2008. Developmental origin of adipocytes: New insights into a pending question. Biol Cell 100:563-575.
5. Callewaert F, Venken K, Ophoff J, De Gendt K, Torcasio A, van Lenthe GH, Van Oosterwyck H, Boonen S, Bouillon R, Verhoeven G, Vanderschueren D. 2009. Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-{alpha}. FASEB J 23:232-240.
6. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295. (Pubitemid 26033933)
7. Crossno JT, Jr., Majka SM, Grazia T, Gill RG, Klemm DJ. 2006. Rosiglitazone promotes development of a novel adipocyte population from bone marrowderived circulating progenitor cells. J Clin Invest 116:3220-3228. (Pubitemid 44878636)
8. Dicker A, Rydén M, Näslund E, Muehlen IE, Wirén M, Lafontan M, Arner P. 2004. Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots. Diabetologia 47:420-428. (Pubitemid 38491238)
9. Dieudonne M, Pecquery R, Boumediene A, Leneveu M, Giudicelli Y. 1998. Androgen receptors in human preadipocytes and adipocytes: Regional specificities and regulation by sex steroids. Am J Physiol 274(6 Pt 1): C1645-C1652.
10. Du J, Zhang L, Wang Z. 2009. Testosterone inhibits the activity of peroxisome proliferator-activated receptor gamma in a transcriptional transaction assay. Pharmazie 64:692-693.
11. Eckertova M, Ondrejcakova M, Krskova K, Zorad S, Jezova D. 2011. Subchronic treatment of rats with oxytocin results in improved adipocyte differentiation and increased gene expression of factors involved in adipogenesis. Br J Pharmacol 162:452-463.
12. Fan W, Yanase T, Nomura M, Okabe T, Goto K, Sato T, Kawano H, Kato S, Nawata H. 2005. Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54:1000-1008. (Pubitemid 40450323)
13. Fernando SM, Rao P, Niel L, Chatterjee D, Stagljar M, Monks DA. 2010. Myocyte androgen receptors increase metabolic rate and improve body composition by reducing fat mass. Endocrinology 151:3125-3132.
14. Garza L, Yang C, Zhao T, Blatt H, Lee M, He H, Stanton D, Carrasco L, Spiegel J, Tobias J, Cotsarelis G. 2011. Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200-rich and CD34-positive hair follicle progenitor cells. J Clin Invest 121:613-622.
15. Gupta V, Bhasin S, Guo W, Singh R, Miki R, Chauhan P, Choong K, Tchkonia T, Lebrasseur NK, Flanagan JN, Hamilton JA, Viereck JC, Narula NS, Kirkland JL, Jasuja R. 2008. Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes. Mol Cell Endocrinol 296:32-40.
16. Hartgens F, Kuipers H. 2004. Effects of androgenic-anabolic steroids in athletes. Sports Med 34:513-554. (Pubitemid 38981844)
17. Hashimoto J, Beadles-Bohling A, Wiren K. 2004. Comparison of RiboGreen and 18S rRNA quantitation for normalizing real-time RT-PCR expression analysis. Biotechniques 36:54-60. (Pubitemid 38076379)
18. Jo J, Gavrilova O, Pack S, Jou W, Mullen S, Sumner AE, Cushman SW, Periwal V. 2009. Hypertrophy and/or hyperplasia: Dynamics of adipose tissue growth. PLoS Comput Biol 5:e1000324.
19. Kalajzic Z, Liu P, Kalajzic I, Du Z, Braut A, Mina M, Canalis E, Rowe D. 2002. Directing the expression of a green fluorescent protein transgene in differentiated osteoblasts: Comparison between rat type I collagen and rat osteocalcin promoters. Bone 31:654-660. (Pubitemid 36092087)
20. Lefterova M, Lazar M. 2009. New developments in adipogenesis. Trends Endocrinol Metab 20:107-114.
21. Lin H-Y, Xu Q, Yeh S, Wang R-S, Sparks JD, Chang C. 2005. Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor. Diabetes 54:1717-1725. (Pubitemid 40770762)
22. Lonn M, Mehlig K, Bengtsson C, Lissner L. 2010. Adipocyte size predicts incidence of type 2 diabetes in women. FASEB J 24:326-331.
23. MacLean HE, Chiu WSM, Notini AJ, Axell A-M, Davey RA, McManus JF, Ma C, Plant DR, Lynch GS, Zajac JD. 2008. Impaired skeletal muscle development and function in male, but not female, genomic androgen receptor knockout mice. FASEB J 22:2676-2689.
24. Maffeis C, Silvagni D, Bonadonna R, Grezzani A, Banzato C, Tato L. 2007. Fat cell size, insulin sensitivity, and inflammation in obese children. J Pediatr 151:647-652. (Pubitemid 350116118)
25. Matsumoto A. 2002. Andropause: Clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 57:M76-M99. (Pubitemid 34177406)
26. Mauras N, Hayes V, Welch S, Rini A, Helgeson K, Dokler M, Veldhuis J, Urban R. 1998. Testosterone deficiency in young men: Marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab 83:1886-1892. (Pubitemid 28496311)
27. Minoura H, Takeshita S, Kimura C, Hirosumi J, Takakura S, Kawamura I, Seki J, Manda T, Mutoh S. 2007. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats. Diabetes Obes Metab 9:369-378. (Pubitemid 46502057)
28. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. 2004. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: The role of PPAR-gamma2 transcription factor and TGFbeta/ BMP signaling pathways. Aging Cell 3:379-389. (Pubitemid 40246708)
29. Mundi MS, Karpyak MV, Koutsari C, Votruba SB, O'Brien PC, Jensen MD. 2010. Body fat distribution, adipocyte size, and metabolic characteristics of nondiabetic adults. J Clin Endocrinol Metab 95:67-73.
30. Ophoff J, Van Proeyen K, Callewaert F, De Gendt K, De Bock K, Vanden Bosch A, Verhoeven G, Hespel P, Vanderschueren D. 2009. Androgen signaling in myocytes contributes to the maintenance of muscle mass and fiber type regulation but not to muscle strength or fatigue. Endocrinology 150:3558-3566.
31. Pei L, Tontonoz P. 2004. Fat's loss is bone's gain. J Clin Invest 113:805-806. (Pubitemid 38544136)
32. Roberts R, Hodson L, Dennis A, Neville M, Humphreys S, Harnden K, Micklem K, Frayn K. 2009. Markers of de novo lipogenesis in adipose tissue: Associations with small adipocytes and insulin sensitivity in humans. Diabetologia 52:882-890.
33. Rodeheffer MS, Birsoy KV, Friedman JM. 2008. Identification of white adipocyte progenitor cells in vivo. Cell 135:240-249.
34. Rodriguez-Cuenca S, Monjo MPAM, Roca P. 2005. Depot differences in steroid receptor expression in adipose tissue: Possible role of the local steroid milieu. Am J Physiol Endocrinol Metab 288:E200-E207. (Pubitemid 40023808)
35. Ruschke K, Illes M, Kern M, Kloting I, Fasshauer M, Schon M, Kosacka J, Fitzl G, Kovacs P, Stumvoll M, Bluher M, Kloting N. 2010. Repin1 maybe involved in the regulation of cell size and glucose transport in adipocytes. Biochem Biophys Res Commun 400:246-251.
36. Sato T, Matsumoto T, Yamada T, Watanabe T, Kawano H, Kato S. 2003. Late onset of obesity in male androgen receptor-deficient (AR KO) mice. Biochem Biophys Res Commun 300:167-171. (Pubitemid 36042946)
37. Seidell J, Bjorntorp P, Sjostrom L, Kvist H, Sannerstedt R. 1990. Visceral fat accumulation in men is positively associated with insulin, glucose, and Cpeptide levels, but negatively with testosterone levels. Metabolism 39:897-901. (Pubitemid 20293933)
38. Singh R, Artaza J, Taylor W, Gonzalez-Cadavid N, Bhasin S. 2003. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144:5081-5088. (Pubitemid 37378423)
39. Singh R, Artaza JN, Taylor WE, Braga M, Yuan X, Gonzalez-Cadavid NF, Bhasin S. 2006. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: Nuclear translocation of androgen receptor complex with {beta}- catenin and T-cell factor 4 may bypass canonical wnt signaling to downregulate adipogenic transcription factors. Endocrinology 147:141-154. (Pubitemid 43004269)
40. Snyder E, Walts B, Perusse L, Chagnon Y, Weisnagel S, Rankinen T, Bouchard C. 2004. The human obesity gene map: The 2003 update. Obes Res 12:369-439. (Pubitemid 41132520)
41. Storer TW, Magliano L, Woodhouse L, Lee ML, Dzekov C, Dzekov J, Casaburi R, Bhasin S. 2003. Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab 88:1478-1485. (Pubitemid 36636978)
42. Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto A, Snyder P, Weber T, Berman N, Hull L, Swerdloff R. 2004. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 89:2085-2098. (Pubitemid 38619836)
43. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. 2000. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43:1498-1506. (Pubitemid 32734855)
44. Winer J, Jung C, Shackel I, Williams P. 1999. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270:41-49. (Pubitemid 29230718)
45. Wiren KM, Semirale AA, Hashimoto JG, Zhang XW. 2010. Signaling pathways implicated in androgen regulation of endocortical bone. Bone 46:710-723.
46. Wiren KM, Semirale AA, Zhang XW, Woo A, Tommasini SM, Price C, Schaffler MB, Jepsen KJ. 2008. Targeting of androgen receptor in bone reveals a lack of androgen anabolic action and inhibition of osteogenesis A model for compartment-specific androgen action in the skeleton. Bone 43:440-451.
47. Wiren KM, Toombs AR, Semirale AA, Zhang X. 2006. Osteoblast and osteocyte apoptosis associated with androgen action in bone: Requirement of increased Bax/Bcl-2 ratio. Bone 38:637-651.
48. Wiren KM, Zhang XW, Toombs AR, Kasparcova V, Gentile MA, Harada S, Jepsen KJ. 2004. Targeted overexpression of androgen receptor in osteoblasts: Unexpected complex bone phenotype in growing animals. Endocrinology 145:3507-3522. (Pubitemid 38830023)
49. Woodhouse LJ, Gupta N, Bhasin M, Singh AB, Ross R, Phillips J, Bhasin S. 2004. Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J Clin Endocrinol Metab 89:718-726. (Pubitemid 38269883)
50. Yeh S, Tsai M, Xu Q, Mu X, Lardy H, Huang K, Lin H, Yeh S, Altuwaijri S, Zhou X, Xing L, Boyce B, Hung M, Zhang S, Gan L, Chang C, Hung M. 2002. Generation and characterization of androgen receptor knockout (ARKO) mice: An in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA 99:13498-13503. (Pubitemid 35215410)
51. Yu IC, Lin H-Y, Liu N-C, Wang R-S, Sparks JD, Yeh S, Chang C. 2008. Hyperleptinemia without obesity in male mice lacking androgen receptor in adipose tissue. Endocrinology 149:2361-2368. (Pubitemid 351574489)